The stem cell sector is fueled by innovation and rapid change. To keep you up-to-date, we recently released new coverage of the industry. Check it out and let us know what you think! [Read more…]
Cord Blood
Because cord blood present within a newborn’s umbilical is rich with stem cells, it can be collected and stored for future medical use.
No Longer Just for Humans — Cord Blood Banking Now Available to Horses Too
VetiCell, LLC, has announced that it is launching a proactive stem cell storage program for animals, in which it will collect stem cells from the umbilical cord of horses or from the reproductive tissues of dogs following spay or neuter.
VetiCell is a sister company to AlphaCord, a human cord blood bank, with the two companies having the same owner and staff.
Currently, there are a couple companies operating in the veterinary stem cell market that collect stem cells through invasive methods (adipose or bone marrow). However, VetiCell’s new model is to collect veterinary stem cells without surgery from the umbilical cord of horses or from reproductive tissues after canine spay and neuter. These methods require no additional invasive surgery to collect an animal’s stem cells.
Since 2006, BioInformant has been tracking the human stem cell banking market. Initially, the market was focused on the storage of umbilical cord blood, although it has expanded over the past ten years to include the storage of other types of stem cells, including those present within cord tissue, dental pulp, adipose tissue, and more.
With hundreds of human cord blood banks now competing worldwide, it will be interesting to see whether any of them add equine cord blood banking to their portfolio of human stem cell storage services.
Rates of Private Cord Blood Storage in the United States and Worldwide
BioInformant was interviewed by Vogue magazine for an article about the U.S. private cord blood storage industry, authored by Lauren Mechling. Vogue is a fashion and lifestyle magazine that is published monthly in 23 different national and regional editions. It has a total circulation of nearly 1.25 million readers and is one of the Top 25 Consumer Magazines in the U.S.
Private Cord Blood Storage | BI Research Data on Vogue
In this article:
- Vogue Magazine’s Interest On Cord Blood Units
- BioInformant’s Quoted Information on Vogue Magazine
- Global Statistics on Private Cord Blood Storage Banks
Vogue Magazine’s Interest On Cord Blood Units
Vogue needed an approximate quantity of how many cord blood units are now stored within private (family) cord blood banks within the United States. The article released by Vogue was titled, “Could Umbilical Cord Blood Banking Save Your Baby’s Life? Inside the Pregnancy Phenomenon.”
BioInformant’s Quoted Information on Vogue Magazine
BioInformant’s contribution to the article was this important statistic: “There are 1.9M units in private US cord banks, according to market research firm BioInformant.”
Global Statistics on Private Cord Blood Storage Banks
While Vogue did not inquire about global statistics, many of our readers and clients are based outside of the United States. As of January 2016, there were approximately 4.3 million units stored in private cord blood storage banks worldwide.
To view the full Vogue article, click here: http://www.vogue.com/13394836/blood-cord-banking-stem-cell-therapy-benefits-and-costs/
To learn more about the cord blood market, including rates of public and private storage, view the “Global Cord Blood Banking Industry Report.”
How many cord blood units worldwide do you think are in private banks right now? Share your thoughts in the comments section.
Up Next: Cord Blood Industry Trends – Clinical Trials, Publications, Patents, and Grants
We Analyzed a Decade of Historical Information on Cord Blood & Cord Tissue Markets (This Is What We Learned)
The cord blood banking market is complex. There are regions experiencing growth and regions experiencing decline. There are extremely successful cord blood banks, and banks that are going out of business or being acquired by the competition.
In addition, there are unique opportunities occurring within the cord blood space that are based on emerging technologies, such as ex vivo expansion of cord blood.
The cord tissue market is also complex, although for different reasons. Today, half of all cord blood banks worldwide offer this service and the number is accelerating. Interestingly, the mesenchymal stem cells (MSCs) contained in cord tissue may have growing opportunities relative to the hematopoietic stem cells (HSCs) contained in cord blood, because MSCs just surpassed HSCs in the scientific literature for the first time in history.
For this reason, BioInformant is offering industry-leading market intelligence for both cord blood and cord tissue markets for the next 14 days only.
Act by Feb 29, 2016, and you can get two reports for the price of one, a savings of $3,795.
CORD BLOOD + CORD TISSUE PACKAGE:
- Complete 2015-16 Global Cord Blood Banking Industry Report
- Mesenchymal Stem Cells – Advances & Applications
This is an exclusive offer available only to BioInformant readers, so enter the coupon code “CordBloodCordTissue” during checkout (for either product) and you will automatically receive the other report for free.
To compete within the global cord blood banking market, you need to be informed about both cord blood and cord tissue markets. This is your opportunity to get a strategic edge.
Texas Stem Cell Partners with Cesca Therapeutics to Use AutoXpress® Technology
Located in Rancho Cordova, California, Cesca Therapeutics specializes in the research, development, and commercialization of autologous cell-based therapeutics for regenerative medicine applications. With the stem cell and cord blood marketplace, the company is best known for it automated blood and bone marrow processing systems, such as the AutoXpress® Platform (AXP®), the MarrowXpress® Platform, the BioArchive® System, and others.
Already a dominant player with the cord blood banking markets, Cesca Therapeutics continues its dominance with today’s announcement that the Texas Stem Cell has entered into an agreement to use Cesca’s AutoXpress technology.
Located in Houston, Texas Stem Cell is a stem cell bank that offer the storage of newborn umbilical cord blood, cord tissue, and placenta. As a “hybrid” bank, it offers both private (fee-based) storage and public (free) donation of stem cell samples.
In news released today, the companies announced:
“Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that Texas Stem Cell has committed to utilizing Cesca’s AutoXpress® AXP technology for its cord blood banking business. The AXP platform includes a ‘smart’ processing device and sterile disposable that automatically concentrates the stem cells from a cord blood unit in less than one hour and delivers them directly into Cesca’s patented sample bag which is optimized for cryopreservation and storage.
Cesca’s AXP technology is widely used in cord blood banks around the world and has been referenced in dozens of clinical publications. Recently, clinical focus on cord blood has expanded due to the emergence of protocols enabling the expansion of cord blood cells in vitro, for subsequent therapeutic use in treatments for many forms of blood cancers including leukemia and lymphomas.”
To learn more about the agreement, see the company press release from Cesca Therapeutics.
About BioInformant
As the first and only market research firm to specialize in the stem cell industry, BioInformant research has been cited by the Wall Street Journal, Xconomy, AABB, and Vogue Magazine. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.
- « Previous Page
- 1
- …
- 50
- 51
- 52
- 53
- 54
- …
- 62
- Next Page »